Skip to main content
Content Starts Here GSA Federal Advisory Committee Act (FACA) Database Skip to main content

Committee Detail

Note: An Annual Comprehensive Review, as required by §7 of the Federal Advisory Committee Act, is conducted each year on committee data entered for the previous fiscal year (referred to as the reporting year). The data for the reporting year is not considered verified until this review is complete and the data is moved to history for an agency/department. See the Data From Previous Years section at the bottom of this page for the committee’s historical, verified data.

Details on agency responses to committee recommendations can be found under the Performance Measures section for each committee in the fields “Agency Feedback” and “Agency Feedback Comment.”


HHS - 5252 - Medicare Evidence Development Coverage Advisory Committee - Authorized by Law
Hide Section - GENERAL INFORMATION

GENERAL INFORMATION

Committee NameMedicare Evidence Development Coverage Advisory CommitteeAgency NameDepartment of Health and Human Services
Fiscal Year2022Committee Number5252
Original Establishment Date11/24/1998Committee StatusChartered
Actual Termination Date Committee URLhttps://www.cms.gov/Regulations-and-Guidance/Gu...
New Committee This FYNoPresidential Appointments*No
Terminated This FYNoMax Number of Members*100
Current Charter Date11/24/2022Designated Fed Officer Position Title*DFO
Date Of Renewal Charter11/24/2024Designated Federal Officer PrefixMs.
Projected Termination Date Designated Federal Officer First Name*Leah
Exempt From Renewal*NoDesignated Federal Officer Middle Name
Specific Termination AuthorityDesignated Federal Officer Last Name*Cromwell
Establishment Authority*Authorized by LawDesignated Federal Officer Suffix
Specific Establishment Authority*42 USC 217a: Sec. 222 of the PHS Act, as amendedDesignated Federal Officer Phone*(410) 786-2243
Effective Date Of Authority*11/17/1962Designated Federal Officer Fax*(410) 786-9286
Exempt From EO 13875 Discretionary CmteNot ApplicableDesignated Federal Officer Email*leah.cromwell1@cms.hhs.gov
Committee Type*Continuing
Presidential*No
Committee Function*Scientific Technical Program Advisory Board
Hide Section - RECOMMENDATION/JUSTIFICATIONS

RECOMMENDATION/JUSTIFICATIONS

Agency Recommendation*Continue
Legislation to Terminate RequiredNot Applicable
Legislation StatusNot Applicable
How does cmte accomplish its purpose?*The Medicare Evidence Development & Coverage Advisory Committee (MEDCAC) reviews and evaluates medical literature, technical assessments, etc., and examines data and information on the effectiveness and appropriateness of medical services and items that are covered under Medicare or eligible for coverage under Medicare. The Committee works from an agenda that lists specific issues and develops technical advice to assist the Centers for Medicare & Medicaid Services (CMS) in determining reasonable and necessary applications of medical services, items, and technologies. The Committee may be asked to develop recommendations about specific issues of Medicare coverage and/or to review and comment upon proposed or existing Medicare coverage policies. The Committee may also be asked to comment on pertinent aspects of proposals being considered under CMS's demonstration authority.
How is membership balanced?*The members were selected from among authorities in clinical and administrative medicine, biologic and physical sciences, public health administration, health care data and information management and analysis, the economics of health care, medical ethics, and other related professions. The members include at large standing members, 10 of which are patient advocates and 10 of which are industry representatives. Members are selected based upon their individual qualifications and not solely as representatives of professional associations or societies. We wish to ensure adequate representation of those enrolled in the Medicare program including but not limited to, racial and ethnic groups, individuals with disabilities, and individuals from across the gender spectrum. Therefore, we encourage nominations of qualified candidates who can represent these lived experiences.

The Committee includes underrepresented groups in clinical, administrative and medical sciences. The membership represent the North, South, East and West geographic areas of the United States. Members serve staggered two-year terms, replacing approximately one-third of the Committee each year.
How frequent & relevant are cmte mtgs?*CCSQ, Coverage & Analysis Group has held, on average, two MEDCAC meetings per year. Due to the COVID-19 pandemic, CAG was unable to conduct an in-person meeting due to building closures and restrictions for safety reasons. We were able to conduct one virtual MEDCAC for FY21 and in trying to keep staff and committee members safe, we will conduct our December 2022 MEDCAC meeting virtually. We can have up to eight MEDCAC meetings per FY.
Why advice can't be obtained elsewhere?*The Committee provides advice on clinical coverage issues. No other organization has the appropriate range of clinical, scientific, and medical expertise to perform these functions.
Why close or partially close meetings?No formal committee meetings have been closed to the public.
Recommendation RemarksWe did not have a MEDCAC in FY22 because we are working with our sister agency, the Agency for Healthcare Research and Quality (AHRQ) and the technology assessment took longer than expected. We decided to move the date from September 28, 2022 to December 7, 2022 to allow extra time for the evidence based practice center to complete the technology assessment for the MEDCAC.
Hide Section - PERFORMANCE MEASURES

PERFORMANCE MEASURES

Outcome Improvement To Health Or Safety*YesAction Reorganize Priorities*Yes
Outcome Trust In GovernmentYesAction Reallocate ResourcesNo
Outcome Major Policy ChangesYesAction Issued New RegulationsNo
Outcome Advance In Scientific ResearchYesAction Proposed LegislationNo
Outcome Effective Grant MakingNoAction Approved Grants Or Other PaymentsNo
Outcome Improved Service DeliveryNoAction OtherNo
Outcome Increased Customer SatisfactionYesAction CommentNA
Outcome Implement Laws/Reg RequirementsNoGrants Review*No
Outcome OtherNoNumber Of Grants Reviewed0
Outcome CommentNANumber Of Grants Recommended0
Cost Savings*Unable to DetermineDollar Value Of Grants Recommended$0.00
Cost Savings CommentNAGrants Review CommentNA
Number Of Recommendations*161Access Contact Designated Fed. Officer*Yes
Number Of Recommendations CommentRecommendations remained the same as FY21 as there were no meetings held.Access Agency WebsiteYes
% of Recs Fully Implemented*70.00%Access Committee WebsiteYes
% of Recs Fully Implemented CommentA little more than half of the recommendations have been fully implemented by the Agency.Access GSA FACA WebsiteYes
% of Recs Partially Implemented*8.00%Access PublicationsNo
% of Recs Partially Implemented CommentLess than half of the recommendations were partially implemented by the Agency and we may be able to address additional issues in the future.Access OtherNo
Agency Feedback*YesAccess CommentN/A
Agency Feedback Comment*CMS posts all material associated with the meetings on their website. Prior to the meeting the following documents are posted, the roster, agenda, speakers list, voting questions, and presentations. Following the meeting, the voting scores, meeting minutes, transcript and post meeting documents, such as guidance documents or NCDs are made available on their website. Also, an announcement of any new material posted to the website is sent out via the listserv.Narrative Description*The primary role of the MEDCAC is to provide independent expert scientific advice to CMS in its evaluation of Medicare coverage and assist CMS in making sound decisions based upon the reasoned application of good science. The MEDCAC process encourages public interaction with CMS in gathering information that is utilized in arriving at Medicare coverage decisions, which supports CMS' goal of making the Medicare coverage decision process more open, participatory, transparent and understandable to the public.
Hide Section - COSTS

COSTS

Payments to Non-Federal Members*$0.00Est Payments to Non-Fed Members Next FY*$20,000.00
Payments to Federal Members*$0.00Est. Payments to Fed Members Next FY*$0.00
Payments to Federal Staff*$36,738.00Estimated Payments to Federal Staff*$298,408.00
Payments to Consultants*$0.00Est. Payments to Consultants Next FY*$0.00
Travel Reimb. For Non-Federal Members*$0.00Est Travel Reimb Non-Fed Members nextFY*$0.00
Travel Reimb. For Federal Members*$0.00Est Travel Reimb For Fed Members*$0.00
Travel Reimb. For Federal Staff*$0.00Est. Travel Reimb to Fed Staff Next FY*$0.00
Travel Reimb. For Consultants*$0.00Est Travel Reimb to Consultants Next FY*$0.00
Other Costs$0.00Est. Other Costs Next FY*$24,000.00
Total Costs$36,738.00Est. Total Next FY*$342,408.00
Date Cost Last Modified10/28/2022 8:54 AMEst. Fed Staff Support Next FY*2.17
Federal Staff Support (FTE)*2.17Est Cost Remarks
Cost RemarksThere is no payment to non-federal members for FY because the meeting will take place in FY23.  
Hide Section - Interest Areas

Interest Areas

Category
Area
Health
Health Care
Medical Practitioners
Safety
Treatment
Medicine
Diseases
Health and Health Research
Illnesses
Medicine and Dentistry
Hide Section - MEMBERS,MEETINGS AND ADVISORY REPORTS

MEMBERS,MEETINGS AND ADVISORY REPORTS

To View all the members, meetings and advisory reports for this committee please click here
Hide Section - CHARTERS AND RELATED DOCS

CHARTERS AND RELATED DOCS

No Documents Found
Hide Section - DATA FROM PREVIOUS YEARS

DATA FROM PREVIOUS YEARS

Committee

Data from Previous Years

 
ActionCommittee System IDCommittee NameFiscal Year
 COM-040498Medicare Evidence Development Coverage Advisory Committee2021
 COM-038773Medicare Evidence Development Coverage Advisory Committee2020
 COM-036656Medicare Evidence Development Coverage Advisory Committee2019
 COM-034871Medicare Evidence Development Coverage Advisory Committee2018
 COM-001872Medicare Evidence Development Coverage Advisory Committee2017
 COM-002671Medicare Evidence Development Coverage Advisory Committee2016
 COM-004034Medicare Evidence Development Coverage Advisory Committee2015
 COM-004440Medicare Evidence Development Coverage Advisory Committee2014
 COM-005909Medicare Evidence Development Coverage Advisory Committee2013
 COM-006622Medicare Evidence Development Coverage Advisory Committee2012
 COM-008062Medicare Evidence Development Coverage Advisory Committee2011
 COM-009119Medicare Evidence Development Coverage Advisory Committee2010
 COM-010385Medicare Evidence Development Coverage Advisory Committee2009
 COM-011036Medicare Evidence Development Coverage Advisory Committee2008
 COM-011932Medicare Evidence Development Coverage Advisory Committee2007
 COM-012608Medicare Coverage Advisory Committee2006
 COM-013938Medicare Coverage Advisory Committee2005
 COM-014462Medicare Coverage Advisory Committee2004
 COM-015654Medicare Coverage Advisory Committee2003
 COM-016718Medicare Coverage Advisory Committee2002
 COM-017854Medicare Coverage Advisory Committee2001
 COM-018486Medicare Coverage Advisory Committee2000
 COM-019869Medicare Coverage Advisory Committee1999